Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-release fampridine in multiple sclerosis: gait and neurophysiological effects
2012-005076-34Phase 3Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of dalfampridine in multiple sclerosis (MS), sponsored by Cliniques universitaires Saint-Luc. Started Dec 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-005076-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005076-34.